Field evaluation of Enterotoxigenic Escherichia coli-specific bacteriophage (ΦCJ19) as a feed additive

Korean Journal of Veterinary Research

Volumn 53, Issue 2, 2013, Pages 83-88

  Yoo, Anna ^a   Cha, Seung Bin ^a   Shin, Min Kyoung ^a   Park, Hong Tae ^a   Seo, Hyo Sil ^b   Kim, Jae Won ^b   Yoo, Han Sang ^a  

^a Seoul National University   (South Korea)

^b CJ Corporation   (South Korea)

Author keywords

Bacteriophage; Enterotoxigenic Escherichia coli; Feed additive; Field efficacy

Indexed keywords

EID: 84975842689     PISSN: 24661384     EISSN: 24661392     Source Type: Journal    
DOI: 10.14405/kjvr.2013.53.2.083     Document Type: Article

References (25)

1. Adams MH. Bacteriophages. pp. 18-592, Interscience Publishers, New York, 1959.
2. Bertani G. Lysogenic versus lytic cycle of phage multiplication. Cold Spring Harb Symp Quant Biol 1953, 18, 65-70.
3. Cha SB, Rayamajhi N, Lee WJ, Shin MK, Roh YM, Jung MH, Myoung KS, Ahn YT, Huh CS, Yoo HS. Evaluation of in vitro and in vivo bacteriophage efficacy against Salmonella enterica serovar Enteritidis infection. Korean J Vet Res 2010, 50, 213-220.
4. Cha SB, Yoo AN, Lee WJ, Shin MK, Jung MH, Shin SW, Cho YW, Yoo HS. Effect of bacteriophage in Enterotoxigenic Escherichia coli (ETEC) infected pigs. J Vet Med Sci 2012, 74, 1037-1039.
5. Chernomordik AB. Bacteriophages and their therapeuticprophylactic use. Med Sestra 1989, 48, 44-47.
6. Chibani-Chennoufi S, Sidoti J, Bruttin A, Kutter E, Sarker S, Brüssow H. In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy. Antimicrob Agents Chemother 2004, 48, 2558-2569.
7. d'Herelle F. Bacteriophage as a treatment in acute medical and surgical infections. Bull N Y Acad Med 1931, 7, 329-348.
8. Dibner JJ, Richards JD. Antibiotic growth promoters in agriculture: history and mode of action. Poult Sci 2005, 84, 634-643.
9. Gaastra W, de Graaf FK. Host-specific fimbrial adhesins of noninvasive enterotoxigenic Escherichia coli strains. Microbiol Rev 1982, 46, 129-161.
10. Guttman B, Raya R, Kutter E. Basic phage biology. In: Kutter E, Sulakvelidze A (eds.). Bacteriophages Biology and Applications. 1st ed. pp. 28-66, CRC Press, Boca Raton, 2005.
11. Jamalludeen N, Johnson RP, Shewen PE, Gyles CL. Evaluation of bacteriophages for prevention and treatment of diarrhea due to experimental enterotoxigenic Escherichia coli O149 infection of pigs. Vet Microbiol 2009, 136, 135-141.
12. Kim SJ, Kim JD, Yang SY, Kim NH, Lee CH, Yang DS, Han JH. Evaluation of bacteriophages for prevention and treatment of diarrhea due to experimental enterotoxigenic Escherichia coli K88 infection of weaned piglets. Korean J Vet Serv 2011, 34, 341-352.
13. Koluman A, Dikici A. Antimicrobial resistance of emerging foodborne pathogens: Status quo and global trends. Crit Rev Microbiol 2013, 39, 57-69.
14. Kropinski AM. Phage therapy - Everything old is new again. Can J Infect Dis Med Microbiol 2006, 17, 297-306.
15. Kudva IT, Jelacic S, Tarr PI, Youderian P, Hovde CJ. Biocontrol of Escherichia coli O157 with O157-specific bacteriophages. Appl Environ Microbiol 1999, 65, 3767- 3773.
16. Kutateladze M, Adamia R. Phage therapy experience at the Eliava Institute. Med Mal Infect 2008, 38, 426-430.
17. Levine MM. Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent. J Infect Dis 1987, 155, 377-389.
18. Merril CR, Scholl D, Adhya SL. The prospect for bacteriophage therapy in Western medicine. Nat Rev Drug Discov 2003, 2, 489-497.
19. Noamani BN, Fairbrother JM, Gyles CL. Virulence genes of O149 enterotoxigenic Escherichia coli from outbreaks of postweaning diarrhea in pigs. Vet Microbiol 2003, 97, 87-101.
20. Sheng H, Knecht HJ, Kudva IT, Hovde CJ. Application of bacteriophages to control intestinal Escherichia coli O157:H7 levels in ruminants. Appl Environ Microbiol 2006, 72, 5359- 5366.
21. Smith HW, Huggins MB. Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. J Gen Microbiol 1982, 128, 307- 318.
22. Smith HW, Huggins MB. Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs. J Gen Microbiol 1983, 129, 2659-2675.
23. Sulakvelidze A, Alavidze Z, Morris JG Jr. Bacteriophage therapy. Antimicrob Agents Chemother 2001, 45, 649-659.
24. Summers WC. Bacteriophage research: early history. In: Kutter E, Sulakvelidze A (eds.). Bacteriophages Biology and Applications. 1st ed. pp. 5-27, CRC Press, Boca Raton, 2005.
25. Weber-Dabrowska B, Mulczyk M, Górski A. Bacteriophage therapy of bacterial infections: an update of our institute's experience. Arch Immunol Ther Exp (Warsz) 2000, 48, 547- 551.